BNP Paribas Financial Markets’s HilleVax HLVX Stock Holding History

BNP Paribas Financial Markets’s Portfolio HLVX Stock Details HLVX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-1,098	Closed	-$2.19K	–	5648
2025 Q2	$2.19K	Sell	1,098 -863	-44%	-$1.58K	﹤0.01%	5048
2025 Q1	$2.84K	Sell	1,961 -2,402	-55%	-$4.44K	﹤0.01%	4939
2024 Q4	$9.03K	Buy	+4,363	New	+$8.19K	﹤0.01%	4859
2022 Q4	–	Sell	-8,846	Closed	-$151K	–	4286
2022 Q3	$151K	Buy	+8,846	New	+$129K	﹤0.01%	3607

BNP Paribas Financial Markets's HLVX Position: Q3 2025 in Review

BNP Paribas Financial Markets sold out of HilleVax (HLVX) in Q3 2025, closing a stake of 1,098 shares — an estimated $2.19K sold.

BNP Paribas Financial Markets first reported a position in HLVX in Q3 2022 and held it in 4 quarters. The position peaked at $151K in Q3 2022. 1 fund tracked by Wall St. Rank holds HLVX as of Q3 2025.

BNP Paribas Financial Markets reported no remaining HilleVax position as of Q3 2025 after selling out during the quarter.
BNP Paribas Financial Markets sold 1,098 HilleVax shares in Q3 2025, an estimated $2.19K.
BNP Paribas Financial Markets first reported a position in HilleVax in Q3 2022 and held it in 4 quarters.
BNP Paribas Financial Markets's HilleVax position peaked at $151K in Q3 2022.
1 fund tracked by Wall St. Rank held HilleVax as of Q3 2025.

Based on BNP Paribas Financial Markets's 13F filing for Q3 2025, filed 13 Nov 2025.